SCMP
Sucampo Pharmaceuticals, Inc.
No insider bought or sold Sucampo Pharmaceuticals, Inc. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
SCMP over the last year
Prices for SCMP aren't in yet.
SCMP after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
9 insider filings since 2016, newest first
SCMPSell
Peter A Kiener · Chief Science Officer
$825K−96.0%Dec 11
SCMPSell
Ryuji Ueno · 10% owner
$12.0M−11.0%Sep 13
SCMPSell
Sachiko Kuno · 10% owner
$12.0M−12.0%Sep 13
SCMPBuy
Jason Patrick Meyenburg · Chief Commercial Officer
$49K+15.0%Sep 8
SCMPBuy
Jones W. Bryan · Sr. Vice Pres, BD, Licensing
$50KAug 7
SCMPSell
Peter Greenleaf · CEO
$3.4M−99.0%Nov 30
SCMPSell
Daniel P Getman · Director
$337K−100.0%Nov 30
SCMPSell
Matthias Alder · EVP, Bus. Dev., Lic, G.C.,Sec.
$2.4M−98.0%Nov 28
SCMPSell
Andrew P Smith · CFO
$28K−84.0%Nov 16
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.